According to filings with the U.S. Securities and Exchange Commission, Revbio is raising $2,650,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Grayson Allen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Revbio
RevBio was started with one goal in mindto end medicines 50 year search for a biocompatible bone adhesive. Effective for bone-to-bone as well as bone-to-metal wet field applications, Tetranite is a revolutionary biomaterial that promises to transform bone repairfor both patients and clinicians. Inspired by the marine animal the sandcastle worm, Tetranite is simple chemistry. Bioengineered from the worms secreted protein, our synthetic adhesive is the only patented biomaterial which satisfies both the required and desired properties for a bone adhesive: wet field performance, multi-surface bonding, rapid mechanical stability, and controlled biodegradability.

To learn more about Revbio, visit http://revbio.com/

Contact:
Grayson Allen, Chief Financial Officer
617-947-6246
https://www.linkedin.com/in/graysonallen/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.